Results 231 to 240 of about 25,778 (287)

Microbiota-Driven Immune Dysregulation Along the Gut-Lung-Vascular Axis in Asthma and Atherosclerosis. [PDF]

Biomedicines
Zimbru EL, Zimbru RI, Bojin FM, Chiriac SD, Haidar L, Andor M, Tănasie G, Tatu C, Georgescu M, Uța C, Bănărescu CF, Groza S, Panaitescu C.   +12 more
europepmc   +1 more source

Choline supplementation in preterm infants: effects of four different supplements on choline plasma concentrations. [PDF]

Eur J Nutr
Böckmann KA, Bernhard W, Minarski M, Shunova A, Schwarz J, Poets CF, Franz AR.   +6 more
europepmc   +1 more source

Dapagliflozin enhances gut barrier function in rats with chronic myocardial infarction by modulating gut microbiota balance. [PDF]

Ann Transl Med
Kunasol C, Maneechote C, Apaijai N, Thonusin C, Parbao C, Nawara W, Chattipakorn N, Chattipakorn SC.   +7 more
europepmc   +1 more source

Gut microbiota-cholesterol crosstalk in cardiovascular diseases: mechanisms, metabolites, and therapeutic modulation. [PDF]

Nutr Metab (Lond)
Abavisani M, Sajjadi SM, Ebadpour N, Karav S, Sahebkar A.   +4 more
europepmc   +1 more source

Effect of egg consumption on circulating choline, betaine, and trimethylamine n-oxide in adults: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Nutr J
Aryaeian N, Heydarian A, Tahvilian N, Hosseini H, Ahmadi AR, Davarpanah SH.   +5 more
europepmc   +1 more source

Calorimetric characterization of the stability and activity of trimethylamine-N-oxide (TMAO) demethylase from Methylocella silvestris BL2. [PDF]

Protein Sci
Cappa F, Polidori N, Giuriato D, Correddu D, Marucco A, Sadeghi SJ, Levi R, Catucci G, Gilardi G.   +8 more
europepmc   +1 more source

Investigating the Role of Gut-Derived Neurotoxin TMAO in PTSD Risk Following Traumatic Brain Injury

Donghua He, Qin Kang, Wei Duan, Guilan Li, Rui‐Rong He, Xiaoping Liu, Xing-Guo Gong   +6 more
openalex   +2 more sources

TMAO and Cardiovascular Disease: Exploring Its Potential as a Biomarker. [PDF]

Medicina (Kaunas)
Amaritei O, Mierlan OL, Dinu CA, Chiscop I, Matei MN, Gutu C, Gurau G.   +6 more
europepmc   +1 more source

The Gut Microbiota-Insulin Resistance Axis: Mechanisms, Clinical Implications, and Therapeutic Potential. [PDF]

FASEB Bioadv
Al Qassab M, Chaarani N, Hamou A, Harb R, Jradi A, Zeineddine M, Ghadieh HE, Khattar ZA, Azar S, Kanaan A, Harb F.   +10 more
europepmc   +1 more source

Gut microbiome and chemotherapy-induced cardiotoxicity: A systematic review of evidence and emerging therapies. [PDF]

World J Biol Chem
Abdulaal R, Afara I, Harajli A, Al Mashtoub E, Tarchichi A, Hassan K, Afara A, Abou Fakher J, Salhab S, Fassih I, Tlais M.   +10 more
europepmc   +1 more source